CD8A and graft versus host disease: HDAC6 inhibition impairs effector CD8 T-cell functions during skin inflammation using murine CD8 T cell-related skin disease models, including contact hypersensitivity (CHS) and experimental graft-versus-host disease (GVHD)-like disease [91].